# Pre-medication With N-acetylcysteine and Simethicone to Improve Mucosal Visibility During Gastroduodenoscopy

> **NCT05951712** · NA · COMPLETED · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 800 (actual)

## Conditions studied

- Mucosal Erosion

## Interventions

- **DRUG:** Simethicone 150mg
- **DRUG:** N Acetyl cysteine 600mg
- **DRUG:** Simethicone 150mg plus N Acetyl cysteine 600 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05951712
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-16
- **Primary completion:** 2022-08-20
- **Final completion:** 2022-11-04
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951712, "Pre-medication With N-acetylcysteine and Simethicone to Improve Mucosal Visibility During Gastroduodenoscopy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05951712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*